Taiwan Biomaterial Co., Ltd. (TPEX:6649)
Taiwan · Delayed Price · Currency is TWD 73.80
+3.30 (4.68%)
Oct 9, 2025, 1:30 PM CST
Taiwan Biomaterial Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 157.98 | 96.57 | 72.84 | 127.31 | 41.67 | 18.08 | Upgrade | |
Revenue Growth (YoY) | 141.09% | 32.59% | -42.79% | 205.48% | 130.56% | 9.26% | Upgrade |
Cost of Revenue | 59.75 | 39.27 | 25.72 | 36.94 | 9.52 | 3.33 | Upgrade |
Gross Profit | 98.24 | 57.31 | 47.12 | 90.37 | 32.15 | 14.74 | Upgrade |
Selling, General & Admin | 40.7 | 37.46 | 38.57 | 32.79 | 23.46 | 20.57 | Upgrade |
Research & Development | 25.47 | 31.08 | 22.78 | 32.12 | 65.41 | 59.28 | Upgrade |
Operating Expenses | 66.17 | 68.54 | 61.35 | 64.91 | 88.87 | 79.85 | Upgrade |
Operating Income | 32.07 | -11.24 | -14.23 | 25.46 | -56.72 | -65.11 | Upgrade |
Interest Expense | -0.77 | -0.8 | -0.87 | -0.97 | -1.03 | -1.04 | Upgrade |
Interest & Investment Income | 4.66 | 3.84 | 4.7 | 2.25 | 0.49 | 1.44 | Upgrade |
Currency Exchange Gain (Loss) | -10.12 | 3.67 | 0.27 | 6.67 | -0.63 | -0.74 | Upgrade |
Other Non Operating Income (Expenses) | 1.24 | 2.04 | 1.1 | 0.34 | 10.48 | 10.08 | Upgrade |
EBT Excluding Unusual Items | 27.08 | -2.49 | -9.03 | 33.76 | -47.4 | -55.37 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | -0.04 | 0 | Upgrade |
Pretax Income | 27.08 | -2.49 | -9.03 | 33.76 | -47.44 | -55.37 | Upgrade |
Income Tax Expense | - | -0.76 | 1.1 | - | - | - | Upgrade |
Net Income | 27.08 | -1.73 | -10.13 | 33.76 | -47.44 | -55.37 | Upgrade |
Net Income to Common | 27.08 | -1.73 | -10.13 | 33.76 | -47.44 | -55.37 | Upgrade |
Shares Outstanding (Basic) | 42 | 42 | 42 | 41 | 33 | 33 | Upgrade |
Shares Outstanding (Diluted) | 42 | 42 | 42 | 41 | 33 | 33 | Upgrade |
Shares Change (YoY) | 0.02% | - | 2.73% | 23.90% | - | 3.96% | Upgrade |
EPS (Basic) | 0.64 | -0.04 | -0.24 | 0.83 | -1.44 | -1.68 | Upgrade |
EPS (Diluted) | 0.64 | -0.04 | -0.24 | 0.83 | -1.44 | -1.68 | Upgrade |
Free Cash Flow | 57.94 | 14.74 | -12.74 | -6.36 | -54.3 | -194.25 | Upgrade |
Free Cash Flow Per Share | 1.38 | 0.35 | -0.30 | -0.16 | -1.65 | -5.89 | Upgrade |
Dividend Per Share | - | - | - | 0.200 | - | - | Upgrade |
Gross Margin | 62.18% | 59.34% | 64.69% | 70.99% | 77.15% | 81.57% | Upgrade |
Operating Margin | 20.30% | -11.63% | -19.53% | 20.00% | -136.10% | -360.22% | Upgrade |
Profit Margin | 17.14% | -1.79% | -13.91% | 26.52% | -113.84% | -306.31% | Upgrade |
Free Cash Flow Margin | 36.68% | 15.26% | -17.49% | -5.00% | -130.31% | -1074.68% | Upgrade |
EBITDA | 43.99 | 0.99 | -2.28 | 36.02 | -51.8 | -59.18 | Upgrade |
EBITDA Margin | 27.84% | 1.03% | -3.14% | 28.29% | -124.29% | - | Upgrade |
D&A For EBITDA | 11.92 | 12.23 | 11.94 | 10.55 | 4.92 | 5.93 | Upgrade |
EBIT | 32.07 | -11.24 | -14.23 | 25.46 | -56.72 | -65.11 | Upgrade |
EBIT Margin | 20.30% | -11.63% | -19.53% | 20.00% | -136.10% | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.